Microalbuminuria and estimated glomerular filtration rate

References

• Rosa TT, Palatini P. Clinical value of microalbuminuria in hypertension. J Hypertens. 2000;18(6):645–654.
   PubMed Web of Science ®Google Scholar
• American Diabetic Association Consensus Development Conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. Diabetes Care. 1994;17(11):1357–1361.
   PubMed Web of Science ®Google Scholar
• Scrader J, Luders S, Kulschewski, et al. Microalbuminuria and tubular proteinuria are risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of prospective long term study (MARPLE Study). J Hypertens. 2006;24(3):541–548.
   PubMed Web of Science ®Google Scholar
• Veriava Y, du Toit E, Milne FJ, et al. Hypertension as a cause of endstage renal failure in South Africa. J Hum Hypertens. 1990;4(4):379–383.
   PubMed Web of Science ®Google Scholar
• The United States Renal Data System: USRDS Annual Data Report. 2001.
   Google Scholar
• UK Prospective Diabetes Study (UKPDS). IX: Relationship of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 diabetes mellitus and after 3 months diet therapy. Diabetologia. 1993;36(9):835–842.
   PubMedGoogle Scholar
• Menne J, Chatzikyrkou, Haller H. Microalbuminuria as a risk factor: the influence of the rennin angiotensin system blockade. J Hypertens. 2010;28(10):1983–1993.
   PubMed Web of Science ®Google Scholar
• Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, et al. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989;32(4):219–226.
   PubMed Web of Science ®Google Scholar
• Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol. 2006;17(8):2106–2111.
   PubMed Web of Science ®Google Scholar
• Volpe M, Cosentino F, Ruilope LM. Is it time to measure microalbuminuria in hypertension? J Hypertens. 2003;21(7):1213–1220.
   PubMed Web of Science ®Google Scholar
• Isben H, Olsen MH, Wachtell K, et al. Reduction in albuminuria translates to reduction for endpoint reduction in Hypertension study. Hypertens. 2005;45(2):198–202.
   PubMed Web of Science ®Google Scholar
• Sciarretta S, Valenti V, Tocci G, et al. Association of renal damage with cardiovascular diseases is independent of individual risk profile in hypertension: data from the Italy—Developing Education and Awareness on Microalbuminuria in patients with Hypertensive Disease Study. J Hypertens. 2010;28(2):251–258.
   PubMed Web of Science ®Google Scholar
• Gambaro G, Bonfante L, Gemelli A, et al. High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. Nephrol Dial Transplant. 2011. [Epub ahead of print].
   Google Scholar
• Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851–860.
   PubMed Web of Science ®Google Scholar
• Brenner BM, Cooper ME, de Zeeu D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861–869.
   PubMed Web of Science ®Google Scholar
• Gaede P, Lund-Andersen H, Parving HH, et al. Effect of multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–591.
   PubMed Web of Science ®Google Scholar
• Kunz R, Friedrich C, Wolberg M, et al. Meta-analysis effects of monotherapy and combination therapy with inhibitors of renin angiotensin system on proteinuria in renal disease. Ann Intern Med. 2008;148(1):30–48.
   PubMed Web of Science ®Google Scholar
• Seedat YK, Rayner B, Veriava Y, et al. South African Hypertension Society Guideline 2006. S Afr Med J. 2006;96(4 Pt 2):335–362.
   Web of Science ®Google Scholar
• Revised SEMDSA guidelines for diagnosis and management of type 2 diabetes mellitus for primary health care 2012. Society for Endicrinology Metablolism and Diabetes of South Africa [homepage on the Internet]. Available from: www.semdsa.org.za
   Google Scholar
• Sarafidis PA, Bakris G. A reappraisal of rennin-angiotensin blockade on microalbuminuria development: do they offer anything unique? J Hypertens. 2012;30(1):48–50.
   PubMed Web of Science ®Google Scholar
• Cerezo C, Ruilope LM, Segura J, et al. Microalbuminuria break through under chronic rennin-angiotensin-aldosterone system suppression. J Hypertens, 2012:30(1):204–209.
   PubMed Web of Science ®Google Scholar